Quest Diagnostics shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics shares rose following the release of Q3 financial results that exceeded expectations and FY24 revenue guidance that surpassed estimates.

October 22, 2024 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics reported Q3 financial results that surpassed expectations and provided FY24 revenue guidance above estimates, leading to a rise in share prices.
The better-than-expected Q3 results and higher FY24 revenue guidance are positive indicators for Quest Diagnostics, likely boosting investor confidence and driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100